2022 spells change for EU pharmaceutical legislation
European Pharmaceutical Review
JUNE 24, 2022
This suggests that any of the modelled changes to the regulation could lead to a decrease in the number of OMPs developed… Some of the assessed changes to the regulation could undermine the business model under which OMP?focused THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006. Amsterdam: Gupta Strategists; 2019.
Let's personalize your content